Comments
Loading...

eFFECTOR Therapeutics (EFTR) Stock Price, Quote, News & History

EFTROTCEM
Logo brought to you by Benzinga Data
$0.1800
At close: Jul 12, 5:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-29.19M
Investing Cash Flow (TTM)
-864.00K
Financing Cash Flow (TTM)
35.25M
Free Cash Flow (TTM)
-29.28M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
5.20M

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$5.13M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.00
Earnings Yield % (TTM)
-6285000.00%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.18

Company Debt

Total Debt
$20.02M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$15.51M
Debt to Equity
24.48
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
3.68K / 6.63K
Day Range
- - -
52 Wk Range
0.00 - 0.02
Market Cap
$940.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EFTR

FAQ

Q

How do I buy eFFECTOR Therapeutics (EFTR) stock?

A

You can purchase shares of eFFECTOR Therapeutics (OTCEM:EFTR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are eFFECTOR Therapeutics (EFTR) competitors?

A

There are no as such competitors for eFFECTOR Therapeutics.

Q

What is the forecast, or price target, for eFFECTOR Therapeutics (EFTR) stock?

A

eFFECTOR Therapeutics has a consensus price target of $12.17.

Q

What is the current price for eFFECTOR Therapeutics (EFTR)?

A

The stock price for eFFECTOR Therapeutics (OTCEM: EFTR) is $0.0002 last updated January 16, 2026 at 10:48 AM EST.

Q

Does eFFECTOR Therapeutics (EFTR) pay a dividend?

A

There are no upcoming dividends for eFFECTOR Therapeutics.

Q

When is eFFECTOR Therapeutics (OTCEM:EFTR) reporting earnings?

A

eFFECTOR Therapeutics does not have any upcoming earnings scheduled.

Q

Is eFFECTOR Therapeutics (EFTR) going to split?

A

There is no upcoming split for eFFECTOR Therapeutics.

Q

What sector and industry does eFFECTOR Therapeutics (EFTR) operate in?

A

eFFECTOR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.